Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PensieTinA-asthma
NCT01277523Phase 3Completed
- Sponsor
- Boehringer Ingelheim
- Start
- Jan 2011
- Primary completion
- Oct 2013
- Modality
- Small Molecules
- Countries
- 14
01
Overview
A Phase 3 trial of tiotropium in asthma, sponsored by Boehringer Ingelheim. Started Jan 2011; status: completed.
02
Drugs
tiotropium
03
Conditions
asthma
Beyond the preview
Go deeper on NCT01277523.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01277523.